Modification to the Conditions of the Sanitary Registration COFEPRIS for the Ion Gel ZCM-25®

Modification to the Conditions of the Sanitary Registration COFEPRIS for the Ion Gel ZCM-25®

At the beginning of 2023, a request was made to the Federal Commission for Prevention and Sanitary Risks (COFEPRIS) for a change of National Manufacturer. Finally, on March 22, 2024, Zeyco Laboratories S.A. de C.V. was approved as the manufacturer of Ion Gel ZCM-25®.

    • Related Articles

    • Ion Gel ZCM-25® Publication Clinical 1

      To evaluate the tolerability of the product Ion Gel ZCM-25®, measured as the degree of irritability: edema and/or erythema, during 14 days of administration in healthy subjects. Methods: Twenty research subjects of both genders were recruited, and a ...

    • Ion Gel ZCM-25® Technical Data Sheet

      Read detailed insights into the composition, physical properties, and safety profile of Ion Gel ZCM-25®. For more information, refer to the attached file.

    • Ion Gel ZCM-25® Expanded Provider User Manual for Healthcare Providers

      Surgical Site Infections (SSIs) are a significant concern in healthcare settings, accounting for a significant portion of healthcare-associated infections (HAIs) and resulting in increased costs, morbidity, and mortality. The use of topical ...

    • Efficacy of Ion Gel ZCM-25® in the Antiviral Treatment Against Dengue Virus

      Background: Dengue virus is a significant pathogen responsible for various infections, particularly in healthcare environments, and presents substantial treatment challenges. The necessity for effective antiviral agents against Dengue is critical. ...

    • Ion Gel ZCM-25® Introduction

      Welcome to this video where you will discover everything about the revolutionary Ion Gel ZCM-25®. After watching this video, you will have a complete understanding of the features, benefits, and uses of this incredible Ion Gel ZCM-25®